24_10_STREAM_SiteHeader_CL

TRIAL MANAGEMENT

59:30 phlexglobal second session
Clinical Trials And TMF 101 Learning Series: 2nd Session

The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.

58:59 101 webinar
Clinical Trials And TMF 101 Learning Series: 1st Session

Spark a deeper and broader understanding of the world of Drug Development, Clinical Trials, Regulations, the Trial Master File, and much more – for the industry novice as well as the guru.

4:20 Words of advice.jpg
Sponsors' Advice On Disclosure As A Service

Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.

3:29 scientist lab research data laptop iStock-589973864
Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm

This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.

24:57 phlex document processing thumb
Ensuring Completeness, Accuracy, And Consistency From Source To Archive

Discover how proficient TMF handling can proactively address potential pitfalls, fostering a state of preparedness for regulatory evaluations.

45:43 Security Technology MSP
CTIS Master Series 1: Are You Ready For CTIS?

In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.

12:56 altasciences cns web thumb
Navigating Early Phase CNS-Active Drug Development

Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...

43:43 How RWD Reshapes Patient Recruitment Strategies
How RWD Reshapes Patient Recruitment Strategies

Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.

1:03:03 Oncology Cell
Defining And Implementing The Right Oncology Digital Strategy

A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.

1:00:45 The New Era Of Project Optimus
The New Era Of Project Optimus: Implications For Oncology Development Strategy

In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.

1:24 Digital Data Collection
Modernizing Clinical Research With Patient-Centric Digital Data Collection

Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.

27:41 yes your study is at risk
Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints

Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.

2:11 altasciences sample thumb
Accelerate Your Data With Our Co-Located Clinic And Lab

Watch as we take your fresh sample from our clinic to PBMC separation. This video overviews our optimized workflows that ensure timely processing, transport, and analysis of your samples.

4:31 450x300_ThinkUSA_v2
Think U.S.A.: The Operations Behind Your Clinical Trials

Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.

18:39 keyboard laptop virtual
Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites

Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies...

55:25 CNS Strategies_Altasciences
Strategic Considerations For A Successful CNS Clinical Development Pathway

Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses tactics for a successful clinical development pathway for CNS-active drugs.

1:44 medable oncology
Patient First Solutions For Oncology

Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

48:16 ihc biomarker
Illuminating IHC: From Biomarker To Clinical Trial Assay

Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.

57:46 medable clinops web thumb
Keeping Up With ClinOps: Why And How To Improve Delivery

Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.

55:39 phlexglobal webinar snip thumb
Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy

Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.

53:32 Exploring The Principles Integral To Rare Disease Drug Development
Exploring The Principles Integral To Rare Disease Drug Development

This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.

19:22 medidata ai web snip thumb
CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment

Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.

Webinar: Reimbursement Methods For Sustainable CGT Business Models

Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.

28:42 altasciences the path forward thumb
The Path Forward, Altasciences' Approach To Project Management

Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.

38:39 Why Disclosure Assessments Are The First Step To Improvement
Why Disclosure Assessments Are The First Step To Improvement

Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.

40:26 GettyImages-1444062860 nurse patient clinical
Do Mobile Visits Drive Faster Study Results?

Discover solutions to clinical trial challenges — this on-demand webinar by PCM Trials and Clinical Leader offers insights into the role of mobile nurse visits in overcoming patient dropout and trial delays.

46:45 Cognitive And Pharmacodynamic Testing During First-In-Human CNS Trials
Cognitive, Pharmacodynamic Testing During FIH CNS Trials

A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.

59:34 Clinical Research Without Borders
Clinical Research Without Borders

Explore strategies for navigating global clinical trials with, Afshawn Chakamian of Avidity Biosciences, Dr. Amy Raymond of Worldwide Clinical Trials, Scott Schliebner of Novotech, and Scout’s KimberLee Heidmann.

5:43 Why Disclosure As A Service?
Why Disclosure As A Service?

Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

1:59 Perceptive eClinical
Perceptive eClinical

Learn about a randomization and trial supply management (RTSM) solution that helps keep your trial on track.